Technology evaluation: naked DNA.

  title={Technology evaluation: naked DNA.},
  author={Yaron Ilan},
  journal={Current opinion in molecular therapeutics},
  volume={1 1},
  • Yaron Ilan
  • Published 1999 in Current opinion in molecular therapeutics
Vical and Merck are investigating vaccines against hepatitis B which use Vical's patented naked DNA technology. Both therapeutic and prophylactic vaccines are under development [177132], [268397]. The technology, and subsequent collaboration, stems from the observation by Vical that by directly injecting exogenous cDNA into muscle tissue, protein is expressed which gives rise to a strong immune response and protective immunity [163222]. 

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
1 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Similar Papers

Loading similar papers…